Drinking beet juice associated with reduced restenosis after PCI

Published Date: 02 Mar 2023

Dietary nitrate in the form of beet juice reduces restenosis after percutaneous intervention in a randomized trial.

Read Full News

Latest News

An Old Theory Is Powering a New Approach to Doctor Burnout

A growing body of literature suggests that self-determination theory can help improve both provider well-being and patient care.

Finerenone Benefits Patients With T2D, CKD Across CKM Stages

In patients with T2D and CKD, finerenone lowers the risk for adverse cardiovascular and kidney events compared with placebo, regardless of the CKM syndrome stage at baseline.

Breastfeeding Linked to Lower Cardiometabolic Risk in PMOS

Exclusive breastfeeding is associated with a significant reduction in the cardiometabolic risk among women with polyendocrine metabolic ovarian syndrome after high-risk pregnancies.

Ultrasound Spots Heart Muscle Stiffening in Aortic Stenosis

Ultrafast ultrasound shear wave elastography may offer a feasible and non-invasive method to detect the stiffening of heart muscle in patients with congenital aortic stenosis, a study finds.

Cardiometabolic Issues: When to Suspect Sleep Apnea

Obstructive sleep apnea could be hiding behind subtle symptoms and uncontrolled cardiometabolic disease.

AI-Assisted POCUS Helps NPs, PAs Make Faster Cardiac Calls

New technology offers the ability for bed-side scans.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Latest News

A growing body of literature suggests that self-determination theory can help improve both provider well-being and patient care.

In patients with T2D and CKD, finerenone lowers the risk for adverse cardiovascular and kidney events compared with placebo, regardless of the CKM syndrome stage at baseline.

Exclusive breastfeeding is associated with a significant reduction in the cardiometabolic risk among women with polyendocrine metabolic ovarian syndrome after high-risk pregnancies.

Ultrafast ultrasound shear wave elastography may offer a feasible and non-invasive method to detect the stiffening of heart muscle in patients with congenital aortic stenosis, a study finds.

Obstructive sleep apnea could be hiding behind subtle symptoms and uncontrolled cardiometabolic disease.

New technology offers the ability for bed-side scans.

News All Time

Sleepy Days and Restless Nights Linked to Hypertension Risk

Adults who report excessive daytime sleepiness and difficulty falling asleep face more than triple the risk of developing hypertension.

Gaps Exist in Cardiometabolic Risk Factor Treatment for CKM

Management of cardiometabolic risk factors for cardiovascular-kidney-metabolic syndrome falls short, particularly for younger adults, who have the lowest treatment rates.

Roosevelt’s Public Image and Overlooked Illness

A 2023 review reexamines Yalta through a medical lens, showing how Roosevelt’s deteriorating cardiovascular status may have been underestimated.

FDA Okays Drug to Curb Pancreatitis in Hypertriglyceridemia

The expanded indication makes olezarsen the first therapy approved to reduce the acute pancreatitis risk in adults with severe hypertriglyceridemia.

Statin Initiation Tied to Lower Frailty Risk in Older Adults

Starting statins is associated with a reduced risk for frailty in older adults, including those with prefrailty at baseline.

Synthetic Cannabinoids in Teens: What Clinicians Should Know

French authorities urge clinicians to consider synthetic cannabinoid exposure in adolescents presenting with unexplained neurologic, psychiatric, or cardiovascular symptoms.

Why Does the Heart Rarely Develop Cancer?

New findings suggest the heart’s mechanical activity actively restrains tumor growth, revealing a pathway that could inspire future cancer treatments.

New Vericiguat Analysis Shows Hidden Benefits in HF

Vericiguat may be beneficial for heart failure with reduced ejection fraction, according to a new study that accounted for mortality events occurring after heart failure hospitalization.

Inpatient Rehab Underutilized After Stroke, TBI

Fewer than 1 in 4 patients with stroke and fewer than 1 in 7 with traumatic brain injury are discharged from the hospital to an inpatient rehabilitation facility, new data show.

Early Treatment Cuts Heart Risk in Hypercholesterolaemia

Early treatment of FH in childhood and adolescence may reduce lifetime cholesterol burden and lower the cardiovascular risk compared to treatment starting later in adulthood.

Menopause Age Linked to Higher Hypercholesterolaemia Burden

Women experience a significant increase in hypercholesterolaemia diagnoses and related comorbidities around the menopausal transition compared with men.

Metyrapone Reduces BP in Mild Autonomous Cortisol Secretion

Evening metyrapone treatment reduces blood pressure at the supine position and epicardial fat in patients with mild autonomous cortisol secretion.

Ultraprocessed Foods: A Factor in Male Fertility Decline?

Emerging evidence links heavily processed dietary patterns to poor semen quality and hormonal changes that may influence reproductive health.

New Atrial Fibrillation May Speed Kidney Decline in Adults

In working-age adults, new-onset atrial fibrillation is linked to a faster decline in kidney function and a substantially higher risk of experiencing a 30% or greater reduction in kidney function.

Gene Therapy Appears to Be Safe in FA Cardiomyopathy

Intravenous gene therapy delivering the frataxin gene appears safe and is associated with preliminary signs of reduced heart damage in patients with Friedreich ataxia cardiomyopathy.

Glycemic Benefits of Testosterone Therapy Wane After 2 Years

A follow-up of the T4DM trial in men with prediabetes or recent-onset type 2 diabetes show no further glycemic improvement after 2 years without ongoing lifestyle modification.

Recommended News For You

Metastatic breast cancer can be effectively treated with cyclical estrogen and anti-estrogen therapy.

Enhanced CAR T cell therapy offers new strategy for lymphoma

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

Adding cell-based vaccine to liver cancer therapy can slow cancer progression

Males with early-onset colorectal cancer are at risk, according to a study.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

Q&A: When will individuals be able to receive customized cancer vaccines?

Recommended Articles For You

Strategic Practices in Oncology for Specialists 

A Comprehensive Guide To Understanding Plasma Osmolality 

Revolutionizing Cancer Care: The Impact of Darzalex Faspro 

Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

2.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

3.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

4.

Providing essential cancer care to rural communities

5.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

1.

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide 

2.

Practical Solutions in Oncology and Patient Outcomes

3.

Exploring the Use of Bevacizumab in Treating Different Types of Cancers 

4.

Hematopoietic Niche Reconditioning Strategies in Blood Disorders

5.

Liquid Biopsies Unveiling the Future of Precision Cancer Management by 2025

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

3.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

4.

Navigating the Complexities of Ph Negative ALL - Part VIII

5.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot